Attached files

file filename
8-K - 8-K - GENTHERM Incthrm-8k_20150224.htm

Exhibit 99.1

 

NEWS RELEASE for February 24, 2015 at 6:00 AM ET

 

 

GENTHERM REPORTS ITS 2014 YEAR-END AND FOURTH QUARTER RESULTS

 

Revenue for the Year Up 23% Over 2013, Net Earnings More than Double

 

NORTHVILLE, MI (February 24, 2015) . . . Gentherm (NASDAQ-GS:THRM), the global market leader and developer of innovative thermal management technologies, today announced its financial results for the fourth quarter and year ended December 31, 2014.

 

For the 2014 full year, revenues increased 23 percent year over year to $811.3 million and net income attributable to common shareholders more than doubled from the prior year to $70.1 million.

 

President and CEO Daniel R. Coker said, “We believe 2014 was a great year as we achieved nearly all of the goals we set out for ourselves, especially in growing our bottom line.  Our strong top line and bottom line results for 2014 again demonstrate our ability to drive revenues and profit as we expand globally in North America, Europe and Asia. We have doubled our business in the past three years and completed an important strategic acquisition, all of which has been accomplished with internal funding.

 

“In recent weeks, to better serve our customers all over the world, meet the demand for our products and balance our manufacturing needs as we grow, we opened a new office in Houston and began the process of building new manufacturing facilities in Vietnam and Macedonia,” Coker added. “We are working hard to integrate the manufacturing skills of Global Thermoelectric, which is now the basis of our new Gentherm Power Technologies (“GPT”) group, with Gentherm’s technology and scientific advancements.  We are now poised to go after business not just in Global’s legacy oil and gas markets but in the industrial and mobile power generation markets as well.

 

“One of our long term goals is to generate 25 percent of our revenue from non-automotive markets and we believe we are beginning to make progress in achieving that goal.  In addition to our bedding and mattress business, we are moving quickly forward with investigating new opportunities in the medical, aerospace, industrial and commercial consumer markets.”

 

2014 Year-End Financial Highlights

For 2014, revenues were $811.3 million, compared with $662.1 million in 2013.  The year-over-year revenue increase was driven by continued strong shipments of the Company’s CCS systems and $24.2 million in revenue from GPT.  CCS revenue increased year over year in 2014 by $84.8 million, or 32 percent, to $347.5 million.  Seat heater revenue increased year over year by $30.7 million, or 11 percent, to $313.2 million.  The Company also had significant growth in its heated steering wheel product with a year-over-year increase of $8.1 million, or 29 percent, to $36.1 million.

 

Foreign currency translation of the Company’s Euro-denominated revenue for 2014, which was €154.6 million compared with €141.9 million during 2013, increased the US Dollar-reported product revenue by approximately $538,000.  The average US Dollar/Euro exchange rate for 2014 was 1.3317 compared with 1.3282 for 2013.

Net income attributable to common shareholders for 2014 was $70.1 million, or $1.98 per basic share and $1.95 per diluted share, which included $1.1 million in fees and expenses associated with the acquisition of GPT.  Net income attributable to common shareholders for 2013 was $32.2 million, or $0.96 per basic share and $0.94 per diluted share.  During 2013, the Company incurred $2.4 million in fees, legal and other expenses associated with the acquisition of shares in our German subsidiary.

 

Further non-cash purchase accounting impacts associated with the recent acquisitions are detailed in the Acquisition Transaction Expenses, Purchase Accounting Impacts and Other Effects table accompanying the release.

 

 


Exhibit 99.1

 

Gross margin as a percentage of revenue for 2014 was 29.8 percent compared with 26.4 percent for 2013. This increase was due to a favorable change in product mix, greater coverage of fixed manufacturing costs at the higher volume levels, favorable contribution from the Company’s new electronics manufacturing facility in China and foreign currency impact on production expenses in the Mexican Peso and Ukraine Hryvna.  Additionally, the Company recorded a favorable adjustment to its warranty accrual totaling $3.7 million lowering its cost of sales during 2014.The favorable product mix is primarily due to the greater sales growth in CCS products on which Gentherm has historically had better margin performance.

 

Adjusted EBITDA for 2014 was $131.4 million compared with Adjusted EBITDA of $81.5 million for the comparable period of the prior year, an increase of $49.8 million or 61 percent.  Adjusted EBITDA (which is a non-GAAP measure) is provided to help shareholders understand Gentherm’s results of operations due to the significant amount of acquisition-related amortization recorded against the Company’s earnings.  This non-GAAP financial measure should be viewed in addition to, and not as an alternative for, Gentherm’s reported results prepared in accordance with GAAP.

 

The Company’s balance sheet as of December 31, 2014, had total cash and cash equivalents of $85.7 million, total assets of $557.9 million, shareholders’ equity of $294.2 million and total debt of $90.8 million.

 

Fourth Quarter Financial Highlights

For the 2014 fourth quarter, revenues were up 13 percent to $205.2 million from $182.3 million in the prior year period.  The year-over-year revenue increase was driven by continued strong shipments of the Company’s CCS systems and $7.5 million in revenue from GPT.  

 

“Revenue for the fourth quarter came in as we expected,” Coker said. “We were, however, unfavorably impacted by fluctuations in foreign currency exchange rates including the dramatic drop in the value of the Euro which lowered our fourth quarter revenues by $4.6 million compared to 2013. Despite this, we again hit our goals and targets.”

 

Foreign currency translation of the Company’s Euro-denominated product revenue for this year’s fourth quarter had an impact on its product revenue results since the average U.S. Dollar/Euro exchange rate in this year’s fourth quarter was 1.2488 compared to 1.3694 in the fourth quarter of 2013.  Gentherm product revenues denominated in the Euro were €38.3 million during the fourth quarter of 2014 versus €35.8 million during the fourth quarter of 2013.  Further weakening in the Euro since the end of the 2014 fourth quarter will continue to have an unfavorable impact on our revenues during future periods.

 

CCS revenue in the 2014 fourth quarter, compared to the 2013 fourth quarter, increased by $16.6 million, or 22 percent, to $92.6 million.  This increase was partially the result of new program launches since the fourth quarter 2013 and strong production volumes and sales of vehicles equipped with CCS systems, particularly vehicles in the luxury segment.  Additionally, certain vehicles that have been redesigned since the 2013 fourth quarter are experiencing very strong production and sales levels, including the General Motors full size SUV platform (“K2XX”) and the Jeep Grand Cherokee.  

  

Seat heater revenue in this year’s fourth quarter decreased year over year by approximately $3.1 million, or 4 percent, to $72.5 million, reflecting the unfavorable Euro exchange rate and the impact of higher CCS volumes which sometimes contain seat heater elements.  These were partially offset by strong production volumes on General Motors’ K2XX platform.  The Company also had significant sales growth of its steering wheel heater product, which increased $1.3 million, or 16 percent year over year, to $9.4 million.  

Net income attributable to common shareholders for the 2014 fourth quarter was $19.8 million, or $0.56 per basic share and $0.55 per diluted share.  Net income attributable to common shareholders for the fourth quarter of 2013 was $11.0 million, or $0.31 per basic and diluted share, which included $503,000 in fees, legal and other expenses associated with the acquisition of additional shares in our German subsidiary.  The Company did not incur any such expenses in the fourth quarter of 2014.  

 

Gross margin as a percentage of revenue for this year’s fourth quarter increased to 30.3 percent, up from 27.2 percent for the 2013 fourth quarter.  

 

Adjusted EBITDA for the 2014 fourth quarter was $35.7 million, up $10.0 million or 39 percent, compared with Adjusted EBITDA of $25.6 million for the 2013 fourth quarter.  

 

 


Exhibit 99.1

 

Research and Development, Selling, General and Administrative (SG&A) Expenses

Net research and development expenses for 2014 fourth quarter and full year were up year over year $1.7 million, or 13 percent, and $7.7 million, or 15 percent, respectively, to a respective $14.7 million and $57.5 million, when compared to the prior year periods.  The increases reflect additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products.  The increases in net research and development expenses in the 2014 fourth quarter and full year also include $276,000 and $850,000, respectively, due to the inclusion of GPT.  New product development includes automotive heated and cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products.  

 

Selling, general and administrative expenses for the 2014 fourth quarter and full year were $22.9 million and $84.6 million, respectively.  These amounts included selling, general and administrative expenses of GPT, which was acquired during 2014, totaling $2.2 million and $6.2 million in the 2014 fourth quarter and full year, respectively.  The remaining increase in selling, general and administrative expenses totaled $1.5 million and $6.3 million, or 8 percent and 10 percent, respectively, for the 2014 fourth quarter and full year.  These increases in expenses are due to increased management incentive compensation costs, higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases.  The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, and increasing sales and marketing efforts aimed at supporting our current product development strategy.

 

Guidance

Barring unforeseen economic turbulence, including in the European market or further unfavorable fluctuations of the Euro exchange rate, the 2015 revenue growth outlook remains strong.  The Company is expecting revenue for 2015 to increase 10 to 15 percent over 2014 revenue, which was $811 million.  

 

Conference Call

As previously announced, Gentherm is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review these financial results.  The dial-in number for the call is 1-877-407-4018 or 1-201-689-8471.  The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Gentherm’s website at www.gentherm.com.

 

 


Exhibit 99.1

 

About Gentherm

Gentherm (NASDAQ-GS:THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), cable systems and other electronic devices.  The Company’s advanced technology team is developing more efficient materials for thermoelectric and systems for waste heat recovery and electrical power generation for the automotive markets that may have far-reaching applications for consumer products as well as industrial and technology markets.  Gentherm more than 9,000 employees in facilities in the U.S., Germany, Mexico, China, Canada, Japan, England, Korea, Malta, Hungary and the Ukraine.  For more information, go to www.gentherm.com.

 

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding future sales, products, opportunities, markets, expenses and profits. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. Those risks include, but are not limited to, risks that sales may not increase, additional financing requirements may not be available, new competitors may arise and adverse conditions in the industry in which the Company operates may negatively affect its results. Those and other risks are described in the Company's annual report on Form 10-K for the year ended December 31, 2013 and subsequent reports filed with the Securities and Exchange Commission (SEC), copies of which are available from the SEC or may be obtained from the Company. Except as required by law, the Company assumes no obligation to update the forward-looking statements, which are made as of the date hereof, even if new information becomes available in the future.

 

Contact:    

Allen & Caron Inc

Mike Mason (investors)

michaelm@allencaron.com

(212) 691-8087

Rene Caron (investors)

rene@allencaron.com

Len Hall (media)

len@allencaron.com

(949) 474-4300

 

TABLES FOLLOW


 


Exhibit 99.1

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

 

 

Three Months Ended
December 31,

 

 

Twelve Months Ended
December 31,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Product revenues

$

205,168

 

 

$

182,290

 

 

$

811,300

 

 

$

662,082

 

Cost of sales

 

142,853

 

 

 

132,648

 

 

 

569,618

 

 

 

487,320

 

Gross margin

 

62,315

 

 

 

49,642

 

 

 

241,682

 

 

 

174,762

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net research and development expenses

 

14,653

 

 

 

12,911

 

 

 

57,526

 

 

 

49,873

 

Acquisition transaction expenses

 

 

 

 

503

 

 

 

1,075

 

 

 

2,414

 

Selling, general and administrative

 

22,906

 

 

 

19,211

 

 

 

84,647

 

 

 

72,091

 

Total operating expenses

 

37,559

 

 

 

32,625

 

 

 

143,248

 

 

 

124,378

 

Operating income

 

24,756

 

 

 

17,017

 

 

 

98,434

 

 

 

50,384

 

Interest expense

 

(504

)

 

 

(627

)

 

 

(3,262

)

 

 

(3,543

)

Debt retirement expense

 

(640

)

 

 

 

 

 

(1,370

)

 

 

 

Revaluation of derivatives

 

(225

)

 

 

(195

)

 

 

(518

)

 

 

1,006

 

Foreign currency (loss) gain

 

687

 

 

 

(714

)

 

 

(218

)

 

 

(2,228

)

Income from equity investment

 

 

 

 

117

 

 

 

785

 

 

 

436

 

Other income

 

201

 

 

 

87

 

 

 

370

 

 

 

175

 

Earnings before income tax

 

24,275

 

 

 

15,685

 

 

 

94,221

 

 

 

46,230

 

Income tax expense

 

4,446

 

 

 

4,754

 

 

 

24,102

 

 

 

11,097

 

Net income

 

19,829

 

 

 

10,931

 

 

 

70,119

 

 

 

35,133

 

(Income) loss attributable to non-controlling interest

 

 

 

 

27

 

 

 

 

 

 

(1,313

)

Net income attributable to Gentherm Incorporated

 

19,829

 

 

 

10,958

 

 

 

70,119

 

 

 

33,820

 

Convertible preferred stock dividends

 

 

 

 

 

 

 

 

 

 

(1,622

)

Net income attributable to common shareholders

$

19,829

 

 

$

10,958

 

 

$

70,119

 

 

$

32,198

 

Basic earnings per share

$

0.56

 

 

$

0.31

 

 

$

1.98

 

 

$

0.96

 

Diluted earnings per share

$

0.55

 

 

$

0.31

 

 

$

1.95

 

 

$

0.94

 

Weighted average number of shares – basic

 

35,691

 

 

 

34,814

 

 

 

35,412

 

 

 

33,653

 

Weighted average number of shares – diluted

 

36,232

 

 

 

35,274

 

 

 

36,049

 

 

 

34,124

 

 

MORE-MORE-MORE


 


Exhibit 99.1

 

GENTHERM INCORPORATED

RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME

(Unaudited, in thousands)

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

December 31,

 

December 31,

 

 

2014

 

2013

 

2014

 

2013

 

Net income

$

19,829

 

$

10,931

 

$

70,119

 

$

35,133

 

Add Back:

 

 

  

 

 

  

 

 

  

 

 

 

Income tax expense

 

4,446

 

 

4,754

 

 

24,102

 

 

11,097

 

Interest expense

 

504

 

 

627

 

 

3,262

 

 

3,543

 

Depreciation and amortization

 

10,514

 

 

7,611

 

 

34,652

 

 

30,441

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Debt retirement expense

 

640

 

 

 

1,370

 

 

Acquisition transaction expense

 

 

503

 

 

1,075

 

 

2,414

 

Unrealized currency (gain) loss

 

(491

)

 

1,002

 

 

(1,168

)

 

2,131

 

Unrealized revaluation of derivatives

 

225

 

 

195

 

 

(2,049

)

 

(3,219

)

Adjusted EBITDA

$

35,667

 

$

25,623

 

$

131,363

 

$

81,540

 

 

Use of Non-GAAP Financial Measures

In evaluating its business, Gentherm considers and uses Adjusted EBITDA as a supplemental measure of its operating performance.  The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, transaction expenses, debt retirement expenses, unrealized currency gain or loss and unrealized revaluation of derivatives.  Management believes that Adjusted EBITDA is a meaningful measure of liquidity and the Company's ability to service debt because it provides a measure of cash available for such purposes. Management provides an Adjusted EBITDA measure so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis.

 

The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP.  Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income or other consolidated income statement data prepared in accordance with GAAP.  Gentherm compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.

 

MORE-MORE-MORE


 


Exhibit 99.1

 

GENTHERM INCORPORATED

ACQUISITION TRANSACTION EXPENSES, PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS

(Unaudited and in thousands, except per share data)

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

December 31,

 

Future  Full Year Periods (estimated)

 

 

2014

 

2013

 

2014

 

2013

 

2015

 

2016

 

2017

 

Thereafter

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction related current expenses

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Acquisition transaction expenses

$

 

$

503

 

$

1,075

 

$

2,414

 

$

 

$

 

$

 

$

 

Non-cash purchase accounting impacts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships amortization

$

1,985

 

$

2,054

 

$

8,205

 

$

7,969

 

$

7,719

 

$

7,719

 

$

7,719

 

$

26,607

 

Technology amortization

 

854

 

 

861

 

 

3,486

 

 

3,342

 

 

3,321

 

 

3,321

 

 

2,380

 

 

2,253

 

Product development costs amortization

 

519

 

 

569

 

 

2,207

 

 

2,206

 

 

1,142

 

 

46

 

 

 

Trade name amortization

 

50

 

 

 

104

 

 

 

197

 

 

197

 

 

148

 

 

Order backlog amortization

 

 

 

832

 

 

 

 

 

 

Inventory fair value adjustment

 

 

 

1,098

 

 

 

 

 

 

 

$

3,408

 

$

3,484

 

$

15,932

 

$

13,517

 

$

12,379

 

$

11,283

 

$

10,247

 

$

28,860

 

Tax effect

 

(794

)

 

(1,002

)

 

(4,121

)

 

(4,068

)

 

(2,884

)

 

(2,630

)

 

(2,389

)

 

(6,781

)

Net income effect

 

2,614

 

 

2,985

 

 

12,886

 

 

11,863

 

 

9,495

 

 

8,653

 

 

7,858

 

 

22,079

 

Non-controlling interest effect

 

 

 

 

(155

)

 

 

 

 

Net income available to shareholders effect

$

2,614

 

$

2,985

 

$

12,886

 

$

11,708

 

$

9,495

 

$

8,653

 

$

7,858

 

$

22,079

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share - difference

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.07

 

$

0.09

 

$

0.36

 

$

0.35

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

$

0.07

 

$

0.08

 

$

0.36

 

$

0.34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MORE-MORE-MORE


 


Exhibit 99.1

 

 

GENTHERM INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

 

  

December 31,

 

 

  

2014

 

 

2013

 

ASSETS

  

 

 

 

 

 

 

 

Current Assets:

  

 

 

 

 

 

 

 

Cash & cash equivalents

  

$

85,700

 

 

$

54,885

 

Accounts receivable, less allowance of $2,847 and $1,807, respectively

  

 

136,183

 

 

 

118,283

 

Inventory

  

 

77,643

 

 

 

64,217

 

Derivative financial instruments

  

 

145

 

 

 

67

 

Deferred income tax assets

  

 

6,247

 

 

 

10,616

 

Prepaid expenses and other assets

  

 

29,107

 

 

 

21,864

 

Total current assets

  

 

335,025

 

 

 

269,932

 

Property and equipment, net

  

 

91,727

 

 

 

79,234

 

Goodwill

  

 

30,398

 

 

 

25,809

 

Other intangible assets, net of accumulated amortization of $95,946 and $44,474, respectively

  

 

68,129

 

 

 

83,431

 

Deferred financing costs

  

 

406

 

 

 

1,072

 

Deferred income tax assets

  

 

18,843

 

 

 

7,103

 

Derivative financial instruments

  

 

1,345

 

 

 

1,969

 

Other non-current assets

  

 

12,019

 

 

 

13,373

 

Total assets

  

$

557,892

 

 

$

481,923

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

 

 

 

 

 

 

 

Current Liabilities:

  

 

 

 

 

 

 

 

Accounts payable

  

$

71,434

 

 

$

61,662

 

Accrued liabilities

  

 

68,387

 

 

 

66,783

 

Current maturities of long-term debt

  

 

5,306

 

 

 

21,439

 

Derivative financial instruments

  

 

2,466

 

 

 

2,552

 

Deferred income tax liabilities

 

 

 

 

 

710

 

Total current liabilities

  

 

147,593

 

 

 

153,146

 

Pension benefit obligation

  

 

10,321

 

 

 

6,868

 

Other Liabilities

  

 

2,788

 

 

 

1,601

 

Long-term debt, less current maturities

  

 

85,469

 

 

 

60,881

 

Derivative financial instruments

  

 

6,698

 

 

 

9,358

 

Deferred tax liabilities

  

 

10,804

 

 

 

17,975

 

Total liabilities

  

 

263,673

 

 

 

249,829

 

Shareholders’ equity:

  

 

 

 

 

 

 

 

Common Stock:

  

 

 

 

 

 

 

 

No par value; 55,000,000 shares authorized, 35,696,742 and 34,929,334 issued and outstanding at December 31, 2014 and 2013, respectively

  

 

243,255

 

 

 

232,067

 

Paid-in capital

  

 

(8,224

)

 

 

(9,582

)

Accumulated other comprehensive income

  

 

(25,743

)

 

 

(5,203

)

Accumulated earnings

  

 

84,931

 

 

 

14,812

 

Total shareholders’ equity

  

 

294,219

 

 

 

232,094

 

Total liabilities and shareholders’ equity

  

$

557,892

 

 

$

481,923

 

 

MORE-MORE-MORE

 

 


Exhibit 99.1

 

 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

  

Year Ended December 31,

 

 

  

2014

 

 

2013

 

 

2012

 

Operating Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Net income

  

$

70,119

 

 

$

35,133

 

 

$

24,321

 

Adjustments to reconcile net income to cash provided by operating activities:

  

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

  

 

35,029

 

 

 

31,249

 

 

 

30,627

 

Deferred income tax expense (benefit)

  

 

(11,103

)

 

 

(2,121

)

 

 

618

 

(Gain) loss on revaluation of derivatives

  

 

(1,039

)

 

 

(2,678

)

 

 

167

 

Debt extinguishment expenses

  

 

1,370

 

 

 

 

 

 

 

Stock compensation

  

 

4,652

 

 

 

2,636

 

 

 

1,252

 

Loss on sale of property, plant & equipment

  

 

131

 

 

 

106

 

 

 

555

 

Provision for doubtful accounts

  

 

1,017

 

 

 

(705

)

 

 

533

 

Defined benefit pension plan expense

  

 

820

 

 

 

(659

)

 

 

50

 

(Gain) loss from equity investment

  

 

(785

)

 

 

(436

)

 

 

82

 

Changes in operating assets and liabilities:

  

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

  

 

(16,902

)

 

 

(13,828

)

 

 

(18,367

)

Inventory

  

 

(8,367

)

 

 

(9,600

)

 

 

(5,847

)

Prepaid expenses and other assets

  

 

(5,871

)

 

 

(9,446

)

 

 

(3,228

)

Accounts payable

  

 

6,956

 

 

 

18,255

 

 

 

1,788

 

Accrued liabilities

  

 

4,308

 

 

 

11,888

 

 

 

4,314

 

Net cash provided by operating activities

  

 

80,335

 

 

 

59,794

 

 

 

36,865

 

Investing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Purchases of derivative financial instruments

  

 

 

 

 

 

 

 

(7,787

)

Purchase of non-controlling interest

  

 

 

 

 

(48,567

)

 

 

 

Investment in subsidiary, net of cash acquired

  

 

(31,474

)

 

 

 

 

 

 

Loan to equity investment

  

 

 

 

 

 

 

 

(590

)

Cash invested in corporate owned life insurance

  

 

 

 

 

(266

)

 

 

(265

)

Purchases of property and equipment

  

 

(38,887

)

 

 

(35,861

)

 

 

(26,793

)

Proceeds from the sale of property and equipment

  

 

487

 

 

 

11

 

 

 

40

 

Net cash used in investing activities

  

 

(69,874

)

 

 

(84,683

)

 

 

(35,395

)

Financing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Distribution paid to non-controlling interest

  

 

 

 

 

(3

)

 

 

(290

)

Cash paid for financing costs

  

 

(1,139

)

 

 

 

 

 

(264

)

Borrowing of Debt

  

 

91,592

 

 

 

45,669

 

 

 

3,326

 

Repayments of Debt

  

 

(79,692

)

 

 

(24,496

)

 

 

(22,953

)

Proceeds from public offering of common stock

  

 

 

 

 

 

 

 

75,532

 

Cancellation of restricted stock

  

 

(1,113

)

 

 

 

 

 

 

Excess tax benefit from equity awards

  

 

1,831

 

 

 

2,074

 

 

 

171

 

Proceeds from sale of W.E.T. equity to non-controlling interest

  

 

 

 

 

 

 

 

1,921

 

Redemption of Series C Preferred Stock

  

 

 

 

 

(8,446

)

 

 

(23,340

)

Series C Preferred Stock Holders dividend

  

 

 

 

 

(696

)

 

 

(2,400

)

Proceeds from the exercise of Common Stock options

  

 

7,176

 

 

 

4,801

 

 

 

774

 

Net cash provided by financing activities

  

 

18,655

 

 

 

18,903

 

 

 

32,477

 

Foreign currency effect on cash and cash equivalents

  

 

1,699

 

 

 

2,719

 

 

 

366

 

Net (decrease) increase in cash and cash equivalents

  

 

30,815

 

 

 

(3,267

)

 

 

34,313

 

Cash and cash equivalents at beginning of period

  

 

54,885

 

 

 

58,152

 

 

 

23,839

 

Cash and cash equivalents at end of period

  

$

85,700

 

 

$

54,885

 

 

$

58,152

 

Supplemental disclosure of cash flow information:

  

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

  

$

2,558

 

 

$

2,653

 

 

$

3,545

 

Cash paid for taxes

  

$

21,756

 

 

$

11,326

 

 

$

8,445

 

Supplemental disclosure of non-cash transactions:

  

 

 

 

 

 

 

 

 

 

 

 

Issuance of Common Stock to non-controlling interest

  

$

 

 

$

42,517

 

 

$

7,780

 

Issuance of Common Stock for Series C Preferred Stock conversion

  

$

 

 

$

15,108

 

 

$

1,031

 

Capital Lease

 

 

 

 

 

3,254

 

 

 

 

Common stock issued to directors and employees

  

$

2,706

 

 

$

1,509

 

 

$

429

 

 

# # # #